Figure 3 E shows the highly significant difference in tumor size at d 21 between untreated and R-405-treated mice.
← all excerpts
Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSV.
1
—
—
Figure 3 E shows the highly significant difference in tumor size at d 21 between untreated and R-405-treated mice.